Severe Thrombocytopenia, Extreme Erythroblastosis and Capillary Leak Syndrome in a Metastatic Melanoma Patient. Concurrent Pembrolizumab- and Lenvatinib-Associated Toxicities.
EJC Skin Cancer · 2026 · 4 · 100910
DOI: 10.1016/j.ejcskn.2026.100910 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von I. Patsialos und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patsialos, I., Diamantopoulos, P., Stafylidis, C., Benopoulou, O., Lontou, S., Kouzis, P., Anastasopoulou, A., Gogas, H., & Gkoufa, A. (2026). Severe Thrombocytopenia, Extreme Erythroblastosis and Capillary Leak Syndrome in a Metastatic Melanoma Patient. Concurrent Pembrolizumab- and Lenvatinib-Associated Toxicities. EJC Skin Cancer, 4, 100910. https://doi.org/10.1016/j.ejcskn.2026.100910
Vancouver
Patsialos I, Diamantopoulos P, Stafylidis C, Benopoulou O, Lontou S, Kouzis P, et al. Severe Thrombocytopenia, Extreme Erythroblastosis and Capillary Leak Syndrome in a Metastatic Melanoma Patient. Concurrent Pembrolizumab- and Lenvatinib-Associated Toxicities. EJC Skin Cancer. 2026;4:100910. doi:10.1016/j.ejcskn.2026.100910
BibTeX
@article{Patsialos2026,
author = {Patsialos, I. and Diamantopoulos, P. and Stafylidis, C. and Benopoulou, O. and Lontou, S.-P. and Kouzis, P. and Anastasopoulou, A. and Gogas, H. and Gkoufa, A.},
title = {Severe Thrombocytopenia, Extreme Erythroblastosis and Capillary Leak Syndrome in a Metastatic Melanoma Patient. Concurrent Pembrolizumab- and Lenvatinib-Associated Toxicities},
journal = {EJC Skin Cancer},
year = {2026},
volume = {4},
pages = {100910},
doi = {10.1016/j.ejcskn.2026.100910}
}
EUVIMED